ATE278960T1 - Verbessertes immundiagnostische tests durch verwendung von reduzierende agenzien - Google Patents

Verbessertes immundiagnostische tests durch verwendung von reduzierende agenzien

Info

Publication number
ATE278960T1
ATE278960T1 AT99920678T AT99920678T ATE278960T1 AT E278960 T1 ATE278960 T1 AT E278960T1 AT 99920678 T AT99920678 T AT 99920678T AT 99920678 T AT99920678 T AT 99920678T AT E278960 T1 ATE278960 T1 AT E278960T1
Authority
AT
Austria
Prior art keywords
recombinant protein
purification
recombinant
reducing agents
dtt
Prior art date
Application number
AT99920678T
Other languages
English (en)
Inventor
Geert Maertens
Joost Louwagie
Alfons Bosman
Erwin Sablon
Maan Zrein
Original Assignee
Innogenetics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8237028&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE278960(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Innogenetics Nv filed Critical Innogenetics Nv
Application granted granted Critical
Publication of ATE278960T1 publication Critical patent/ATE278960T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
AT99920678T 1998-04-17 1999-04-15 Verbessertes immundiagnostische tests durch verwendung von reduzierende agenzien ATE278960T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98870087 1998-04-17
PCT/EP1999/002547 WO1999054735A1 (en) 1998-04-17 1999-04-15 Improved immunodiagnostic assays using reducing agents

Publications (1)

Publication Number Publication Date
ATE278960T1 true ATE278960T1 (de) 2004-10-15

Family

ID=8237028

Family Applications (2)

Application Number Title Priority Date Filing Date
AT99920678T ATE278960T1 (de) 1998-04-17 1999-04-15 Verbessertes immundiagnostische tests durch verwendung von reduzierende agenzien
AT04103238T ATE401340T1 (de) 1998-04-17 1999-04-15 Verfahren zur verbesserung der proteinkonformation mit hilfe von reduktionsmitteln

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT04103238T ATE401340T1 (de) 1998-04-17 1999-04-15 Verfahren zur verbesserung der proteinkonformation mit hilfe von reduktionsmitteln

Country Status (21)

Country Link
US (1) US7935490B2 (de)
EP (2) EP1071955B2 (de)
JP (2) JP2002512370A (de)
KR (1) KR20010042807A (de)
CN (1) CN1305589A (de)
AT (2) ATE278960T1 (de)
AU (1) AU751362B2 (de)
BR (1) BRPI9909678B8 (de)
CA (2) CA2658218C (de)
CY (1) CY1108424T1 (de)
CZ (1) CZ298268B6 (de)
DE (2) DE69939132D1 (de)
DK (2) DK1071955T4 (de)
ES (2) ES2230851T5 (de)
HU (1) HUP0101719A3 (de)
IL (1) IL138791A0 (de)
PL (1) PL343469A1 (de)
PT (2) PT1071955E (de)
TR (4) TR200101648T2 (de)
WO (1) WO1999054735A1 (de)
ZA (1) ZA200005445B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1090033B2 (de) * 1998-06-24 2007-12-19 Innogenetics N.V. Hcv hüllproteine partikel : verwendung für therapeutische impfung
AU2001292151B2 (en) * 2000-08-17 2006-05-04 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US7022830B2 (en) 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
JP4261195B2 (ja) * 2001-04-24 2009-04-30 イノジェネティックス・ナムローゼ・フェンノートシャップ 酵母のコア−グリコシル化されたｈｃｖエンベロープタンパク質の発現
JP2004108914A (ja) * 2002-09-18 2004-04-08 Kudo Norio コラーゲンの測定方法
AU2003283365A1 (en) * 2002-11-08 2004-06-07 Innogenetics N.V. HCV vaccine compositions comprising E1 and NS3 peptides
US20050014136A1 (en) * 2003-05-28 2005-01-20 Innogenetics N.V. Modified HCV NS5
DE602004029707D1 (de) * 2003-10-28 2010-12-02 Advanced Life Science Inst Inc Verfahren zum nachweis von hepatitis-c-virus
US20090209737A1 (en) * 2006-07-07 2009-08-20 Pall Corporation Use of denaturing agents during affinity capture
MX2010000745A (es) * 2007-07-16 2010-05-20 Pfizer Procedimientos para mejorar un indice de marcador genomico de animales lecheros y productos lacteos.
WO2009035560A1 (en) * 2007-09-12 2009-03-19 Pfizer, Inc. Methods of using genetic markers and related epistatic interactions
MX2010003610A (es) * 2007-10-03 2010-04-30 Pfizer Marcadores geneticos para ganado astado y sin cuernos, y metodos relacionados.
AU2008343365A1 (en) * 2007-12-17 2009-07-09 Pfizer Inc. Methods of improving genetic profiles of dairy animals and products
JP5476376B2 (ja) * 2008-07-16 2014-04-23 ラジオメーター・メディカル・アー・ペー・エス 高性能固相
CN102081018A (zh) * 2009-11-30 2011-06-01 希森美康株式会社 样品的预处理方法及hcv的免疫测定方法
FR2984328B1 (fr) 2011-12-20 2016-12-30 Bio-Rad Innovations Procede de detection d'une infection par le virus de l'hepatite c
ES2828713T3 (es) * 2014-10-29 2021-05-27 Abbott Lab Ensayos de detección de anticuerpos anti-VHC objeto usando péptidos de captura NS3
CN109870581B (zh) * 2017-12-04 2021-05-04 厦门万泰凯瑞生物技术有限公司 一种定量检测HBsAg的试剂盒及方法
CN109678954B (zh) * 2018-12-29 2022-01-07 山东莱博生物科技有限公司 一对能够特异性识别hcv ns3蛋白的单克隆抗体及其应用
CN110988362B (zh) * 2019-12-20 2023-11-14 迈克生物股份有限公司 抗组蛋白抗体测定试剂、试剂盒及其使用方法
CN112225783B (zh) * 2020-09-16 2021-08-31 东莞市朋志生物科技有限公司 Hcv重组抗原及其突变体
CN112285361B (zh) * 2020-09-27 2023-12-05 中国人民解放军空军军医大学 排除抗-cd38单克隆抗体药物对抗人球蛋白检测干扰的试剂
CN113219169B (zh) * 2021-05-22 2021-12-17 北京金诺百泰生物技术有限公司 生物检测用封闭剂及其制备方法、包被板及应用该包被板的试剂盒
CN115112897B (zh) * 2021-12-10 2024-11-01 中山大学附属第八医院（深圳福田） 一种用于鉴别抗体检测生物学假阳性的方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0139526A2 (de) * 1983-10-20 1985-05-02 Warner-Lambert Company Unlöslich gemachtes stabiles spezifisches Bindungsprotein
US4616078A (en) * 1985-04-08 1986-10-07 Eli Lilly And Company Process for purifying proinsulin-like materials
CA1340877C (en) * 1987-12-28 2000-01-18 Takashi Sugiyama Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology
DE68907996T2 (de) * 1988-05-11 1994-01-05 Abbott Lab Verfahren zur Erhöhung der Spezifizität in kompetitiven Immuntests.
US4923967A (en) * 1988-09-26 1990-05-08 Eli Lilly And Company Purification and refolding of recombinant proteins
DE69133617D1 (de) 1990-04-04 2009-07-23 Novartis Vaccines & Diagnostic Protease von Hepatitis C Virus
US6194140B1 (en) * 1990-04-04 2001-02-27 Chiron Corporation HCV NS3 protein fragments having helicase activity and improved solubility
US5606031A (en) * 1990-04-06 1997-02-25 Lile; Jack Production and purification of biologically active recombinant neurotrophic protein in bacteria
KR0185426B1 (ko) * 1991-06-24 1999-04-01 로버트 피. 블랙버언 씨형 간염 바이러스 폴리펩티드
JP3225468B2 (ja) 1992-08-28 2001-11-05 ダイナボット株式会社 抗体測定用試薬
ATE551423T1 (de) 1993-04-27 2012-04-15 Innogenetics Nv Sequenzen von hepatitis c virus-genotypen sowie ihre verwendungen als therapeutika und diagnostika
PT992580E (pt) 1993-11-04 2005-07-29 Innogenetics Nv Epitopos para celulas t humanas imunodominantes do virus da hepatite c
WO1996000365A1 (en) 1994-06-23 1996-01-04 Energy Answers Corporation System for manufacturing ash products and energy from refuse waste
WO1996004385A2 (en) * 1994-07-29 1996-02-15 Innogenetics N.V. Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
DE4428705A1 (de) * 1994-08-12 1996-02-15 Boehringer Mannheim Gmbh Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus
JPH0862219A (ja) 1994-08-19 1996-03-08 Dainabotsuto Kk 還元型抗原に対する抗体アッセイ試薬及びそれを使用した測定方法
DE69526973T3 (de) 1994-10-21 2010-01-07 Innogenetics N.V. Sequenzen von hepatitis-c-virus genotype 7, und deren verwendung als vorbeugende, therapeutische und diagnostische mittel
US5705330A (en) 1995-04-14 1998-01-06 Abbott Laboratories Chemiluminescent immunoassay for antibody detection
US5616460A (en) * 1995-06-07 1997-04-01 Abbott Laboratories Buffer composition for reagents for immunoassay
JP3945822B2 (ja) 1996-05-24 2007-07-18 カイロン コーポレイション 複数エピトープ融合タンパク質
US6036579A (en) * 1997-01-13 2000-03-14 Rodel Inc. Polymeric polishing pad having photolithographically induced surface patterns(s) and methods relating thereto

Also Published As

Publication number Publication date
TR200202213T2 (tr) 2002-11-21
US7935490B2 (en) 2011-05-03
JP2005185285A (ja) 2005-07-14
ES2310701T3 (es) 2009-01-16
HK1036653A1 (en) 2002-01-11
US20060263854A1 (en) 2006-11-23
PL343469A1 (en) 2001-08-13
IL138791A0 (en) 2001-10-31
DK1471074T3 (da) 2008-11-17
EP1071955A1 (de) 2001-01-31
HUP0101719A2 (hu) 2001-09-28
HUP0101719A3 (en) 2006-05-29
CZ20003819A3 (cs) 2001-10-17
PT1071955E (pt) 2005-02-28
ES2230851T5 (es) 2009-06-25
JP3974620B2 (ja) 2007-09-12
DE69920895D1 (de) 2004-11-11
EP1471074A2 (de) 2004-10-27
ATE401340T1 (de) 2008-08-15
JP2002512370A (ja) 2002-04-23
EP1471074A3 (de) 2004-11-10
EP1071955B1 (de) 2004-10-06
BR9909678A (pt) 2000-12-19
BR9909678B1 (pt) 2013-11-12
TR200003024T2 (tr) 2000-12-21
CA2658218C (en) 2014-10-28
KR20010042807A (ko) 2001-05-25
CA2658218A1 (en) 1999-10-28
DK1071955T4 (da) 2009-06-15
CA2324970A1 (en) 1999-10-28
TR200101648T2 (tr) 2002-06-21
ZA200005445B (en) 2003-01-06
BRPI9909678B8 (pt) 2021-05-25
EP1071955B2 (de) 2009-02-18
AU751362B2 (en) 2002-08-15
CN1305589A (zh) 2001-07-25
DE69939132D1 (de) 2008-08-28
TR200101647T2 (tr) 2002-06-21
DE69920895T2 (de) 2005-10-13
DE69920895T3 (de) 2009-09-03
CY1108424T1 (el) 2014-04-09
PT1471074E (pt) 2008-10-23
CZ298268B6 (cs) 2007-08-08
DK1071955T3 (da) 2005-02-07
ES2230851T3 (es) 2005-05-01
AU3817199A (en) 1999-11-08
CA2324970C (en) 2009-06-30
EP1471074B1 (de) 2008-07-16
WO1999054735A1 (en) 1999-10-28

Similar Documents

Publication Publication Date Title
DE69920895D1 (de) Verbessertes immundiagnostische tests durch verwendung von reduzierende agenzien
DK1075488T4 (da) Proteinoprensning ved ionbytningskromatografi
BR9714505A (pt) para o diabetes.
DE59310046D1 (de) Immunologische Methode zur Bestimmung von HbAIc
DK0760681T3 (da) Modifikation af clostridielle toksiner til anvendelse som transportproteiner
ATE144841T1 (de) Derivatisierte glasträger zur sequenzierung von peptiden und proteinen
DE69841037D1 (de) Charakterisierung von granulozytischer ehrlichia und methoden für ihre verwendung.
NO20035402D0 (no) Fremgangsmåte for å karakterisere polypeptider
EA200401453A1 (ru) Молекулы распознавания на клеточной поверхности, содержащие иммуноглобулиновый домен
ES2173471T3 (es) Analisis para homocisteina y homocisteina desulfurasa a partir de tricomonas viginalis de protozoos.
ES2154703T3 (es) Procedimiento para la deteccion especifica de un factor de coagulacion v activado con una estabilidad elevada frente a proteina c activada.
BR9401481A (pt) Composição de limpeza em microemulsão tendo superiores força solubilizante e desempenho de limpeza e baixa concentração de ingredientes ativos, e, processo para remover manchas oleosas de superfícies
DK1400589T3 (da) Fremgangsmåde til påvisning af prokaryotisk DNA
DE69715883D1 (de) Stabilisierung von interferonen in wässriger lösung durch gummiarabikum
ES502086A0 (es) Metodo para recuperar molibdeno unido organicamente, insolu-ble en agua, de residuos organicos de catalizador agotado derivados de la epoxidacion de olefinas
DK130290A (da) Lymfokiner, dna-sekvenser, som koder for disse lymfokiner og farmaceutiske midler indeholdende disse lymfokiner
GB2289125A (en) Methods of assaying data-repairing enzymes and their alkylated derivatives
Yuasa et al. A new α1-antitrypsin allele PI* Poki: Isoelectric focusing with immobilized pH gradients as a tool for identification of PI variants
SI1527197T1 (sl) Povezava EDG5 polimorfizma V286A z diabetes mellitusom tipa II in vensko trombozo/pljučno embolijoin uporaba le-te
RU2001108203A (ru) Способ газохроматографической идентификации бета, бета'-дихлордиэтилсульфида по индивидуальному индексу удерживания
DE69716106D1 (de) Trennung von proteinen durch kapillarelektrophorese mit aminosäure enthaltenden puffern
EA200000658A1 (ru) Способ и реагенты для количественной оценки реакций в твердой фазе с использованием ямр фтора
FI944686A0 (fi) Kannettavan laite termisiä analyyseja varten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1071955

Country of ref document: EP

UEP Publication of translation of european patent specification

Ref document number: 1071955

Country of ref document: EP